The irony here is that while the President and members of Congress bemoan physician fees, they did not recognize how much money retina specialists saved the U.S. government.
Ironically, the fee for injection of Avastin was halved last year.
I would argue that there should have been incentives to retina physicians who, based on fairly good evidence, knew that avastin was equivalent to Lucentis in terms of efficacy, and who were saving the government a phenomenal amount of money by using Avastin. Not only did the government save money, so did patients. To make it more interesting retina doctors who used Lucentis were actually more profitable in this regards, than those who exclusively used Avastin.
Uvealblues
WASHINGTON—Medicare could have saved more than $1 billion and Medicare patients $275 million over two years if doctors treated a serious eye disease with Genentech's Avastin instead of the company's similar but more expensive drug Lucentis, according to a new government audit.
Link
Ironically, the fee for injection of Avastin was halved last year.
I would argue that there should have been incentives to retina physicians who, based on fairly good evidence, knew that avastin was equivalent to Lucentis in terms of efficacy, and who were saving the government a phenomenal amount of money by using Avastin. Not only did the government save money, so did patients. To make it more interesting retina doctors who used Lucentis were actually more profitable in this regards, than those who exclusively used Avastin.
Uvealblues
WASHINGTON—Medicare could have saved more than $1 billion and Medicare patients $275 million over two years if doctors treated a serious eye disease with Genentech's Avastin instead of the company's similar but more expensive drug Lucentis, according to a new government audit.
Link
Posts
No comments:
Post a Comment